Coave Therapeutics and Th?a Open Innovation sign exclusive licensing, co-development and commercialization agreement for Europe for CTx-PDE6b, a novel gene therapy candidate in retinitis pigm

Rodolphe Clerval, CEO
contact@coavetx.com MEDiSTRAVA Consulting
Sylvie Berrebi,?Eleanor Perkin, Mark Swallow PhD
coavetx@medistrava.com?
Tel: +44 (0)7714 306525 Laboratoires Th?a
Lorraine Kaltenbach
Director of Communication
Lorraine.KALTENBACH@theapharma.com
